Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Therapeutic action of ketogenic enteral nutrition in obese and overweight patients: an interventional study

Cinzia Papadia, Paul Bassett, Gianfranco Cappello, Vincenta Lazarescu, Alastair Forbes and Ray Shidrawi
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.19-2-s118
Clin Med March 2019
Cinzia Papadia
ANo affiliation provided
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Bassett
BResearch@Development, Statsconsultancy, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gianfranco Cappello
CSurgery & Clinical Nutrition, La Sapienza University, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincenta Lazarescu
DGastroenterology, Homerton University Hospital, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alastair Forbes
EGastroenterology, Norwich Medical School, Norwich , UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ray Shidrawi
DGastroenterology, Homerton University Hospital, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Aims

Ketogenic enteral nutrition (KEN) is a modification of Blackburn's protein-sparing modified fast, using a hypocaloric, ketogenic liquid diet. The study is about KEN in overweight and obese patients receiving short treatment of the nutritional solution as 24-hour infusion. It is a retrospective analysis that examines safety, weight loss and body composition changes after three sequential 10-day cycles of KEN therapy.

Methods

Anthropometric and bio-impedance data from 629 patients who underwent KEN were collected before and after completing a 10-day cycle. The study focuses on the change in outcomes from the first cycle to the second cycle and from the first cycle to the third cycle. The following outcomes were explored: weight, waist circumference, body mass index (BMI), fat mass, lean mass, dry lean mass, phase angle, wellness marker and water mass as a percentage of total body weight. The cycle 1, 2 and 3 outcomes were analysed using descriptive statistics (mean, standard deviation, n) summarising the outcome at each cycle. Statistical tests were used to test for significant differences between paired cycle 1 and cycle 2 outcomes and also between paired cycle 1 and cycle 3 outcomes. For normally distributed outcomes, the paired t-test was used. Whereas for skewed outcomes, the Wilcoxon signed-ranks test was used. Scatter plots were used to plot percentage of excess weight loss against phase angle. The Pearson's correlation coefficient was calculated. Regression analysis for the outcome percent change in weight from cycle 1 to cycle 2 for phase angle and basal metabolic rate (BMR)/ weight ratio as predictors was carried out.

Results

The results suggested significant changes for all analysed parameters. There were significant decreases in weight, waist circumference, BMI, fat mass, lean mass, dry lean mass and phase angle. Quantitative changes in lean mass and dry lean mass were negligible with respect to changes in fat mass. There was also a statistically significant increase in water mass as a % of total body weight and wellness marker from cycle 1 to cycle 3. The Pearson's correlation coefficients r=0.18, p=0.004 and r=22, p=0.04 indicated changes in cycle 1 and cycle 3 in percentage of weight excess to be significantly, positively correlated to phase angle. The multivariate linear regression model showed that for a 1 unit increase in BMR/weight there was a 3.3 percent decrease in percent change in weight. KEN treatment was overall well tolerated. 92% of patients on oral hypoglycaemics and 80% of patients on anti-hypertensive medication were able to discontinue their medication safely during KEN therapy.

Conclusion

KEN treatment is safe, well tolerated and results in rapid fat loss without detriment to dry lean mass.

Conflict of interest statement

Disclosure of interest: C Papadia: none declared, P Basset: none declared, G Cappello: none declared, R Shidrawi: Director of Weight Management Systems Ltd.

  • © Royal College of Physicians 2019. All rights reserved.
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Therapeutic action of ketogenic enteral nutrition in obese and overweight patients: an interventional study
Cinzia Papadia, Paul Bassett, Gianfranco Cappello, Vincenta Lazarescu, Alastair Forbes, Ray Shidrawi
Clinical Medicine Mar 2019, 19 (Suppl 2) s118; DOI: 10.7861/clinmedicine.19-2-s118

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Therapeutic action of ketogenic enteral nutrition in obese and overweight patients: an interventional study
Cinzia Papadia, Paul Bassett, Gianfranco Cappello, Vincenta Lazarescu, Alastair Forbes, Ray Shidrawi
Clinical Medicine Mar 2019, 19 (Suppl 2) s118; DOI: 10.7861/clinmedicine.19-2-s118
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Aims
    • Methods
    • Results
    • Conclusion
    • Conflict of interest statement
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Inaccessible back: frustration and misery of lonely patients
  • Methylation of somatostatin receptor 2 gene in neuroendocrine tumours as a predictor of tumour response to peptide receptor radionuclide therapy
  • Viral and other infections in community and primary hypothyroidism – cause or coincidence?
Show more Research and innovation

Similar Articles

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians